{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:18:20Z","timestamp":1790705900693,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T00:00:00Z","timestamp":1304812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s11739-011-0599-2","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T04:46:51Z","timestamp":1304743611000},"page":"101-113","source":"Crossref","is-referenced-by-count":19,"title":["Recent advances in understanding Crohn\u2019s disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Antonio","family":"Di Sabatino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rovedatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Thornton","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,8]]},"reference":[{"key":"599_CR1","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/ajg.2009.190","volume":"104","author":"JK Hou","year":"2009","unstructured":"Hou JK, El-Serag H, Thirumurthi S (2009) Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 104:2100\u20132109","journal-title":"Am J Gastroenterol"},{"key":"599_CR2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0016-5085(90)91273-9","volume":"99","author":"J Zlotogora","year":"1990","unstructured":"Zlotogora J, Zimmerman J, Rachmilewitz D (1990) Crohn\u2019s disease in Ashkenazi Jews. Gastroenterology 99:286\u2013287","journal-title":"Gastroenterology"},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2007.122143","volume":"57","author":"CN Bernstein","year":"2008","unstructured":"Bernstein CN, Shanahan F (2008) Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 57:1185\u20131191","journal-title":"Gut"},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus Jr","year":"2004","unstructured":"Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126:1504\u20131517","journal-title":"Gastroenterology"},{"key":"599_CR5","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3748\/wjg.v12.i23.3668","volume":"12","author":"L Halme","year":"2006","unstructured":"Halme L, Paavola-Sakki P, Turunen U et al (2006) Family and twin studies in inflammatory bowel disease. World J Gastroenterol 12:3668\u20133672","journal-title":"World J Gastroenterol"},{"key":"599_CR6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet 42:1118\u20131125","journal-title":"Nat Genet"},{"key":"599_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation inNOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u2013606","journal-title":"Nature"},{"issue":"(Supp 1)","key":"599_CR8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/mi.2008.42","volume":"1","author":"W Strober","year":"2008","unstructured":"Strober W, Kitani A, Fuss I (2008) The molecular basis of NOD2 susceptibility mutations in Crohn\u2019s disease. Mucosal Immunol 1((Supp 1)):S5\u2013S9","journal-title":"Mucosal Immunol"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bpg.2009.02.005","volume":"23","author":"CG Noomen","year":"2009","unstructured":"Noomen CG, Hommes DW, Fidder HH (2009) Update on genetics in inflammatory disease. Best Pract Res ClinGastroenterol 23:233\u2013243","journal-title":"Best Pract Res ClinGastroenterol"},{"key":"599_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000228554","volume":"27","author":"C Fiocchi","year":"2009","unstructured":"Fiocchi C (2009) Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand? Dig Dis 27:226\u2013235","journal-title":"Dig Dis"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573\u2013621","journal-title":"Annu Rev Immunol"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00173.2003","volume":"286","author":"TY Ma","year":"2004","unstructured":"Ma TY, Iwamoto GK, Hoa NT et al (2004) TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J PhysiolGastrointest Liver Physiol 286:G367\u2013G376","journal-title":"Am J PhysiolGastrointest Liver Physiol"},{"key":"599_CR13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1172\/JCI39134","volume":"119","author":"M Rescigno","year":"2009","unstructured":"Rescigno M, Di Sabatino A (2009) Dendritic cells in intestinal homeostasis and disease. J Clin Invest 119:2441\u20132450","journal-title":"J Clin Invest"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1106442","volume":"307","author":"TT MacDonald","year":"2005","unstructured":"MacDonald TT, Monteleone G (2005) Immunity, inflammation, and allergy in the gut. Science 307:1920\u20131925","journal-title":"Science"},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ibd.20894","volume":"15","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho J (2009) Interleukin-23\/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15:1090\u20131100","journal-title":"Inflamm Bowel Dis"},{"key":"599_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjp.0704063","volume":"133","author":"M Laan","year":"2001","unstructured":"Laan M, L\u00f6tvall J, Chung KF et al (2001) IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 133:200\u2013206","journal-title":"Br J Pharmacol"},{"key":"599_CR17","doi-asserted-by":"crossref","unstructured":"Rovedatti L, Kudo T, Biancheri P et al (2009) Differential regulation of interleukin-17 and interferon-\u03b3 production in inflammatory bowel disease. Gut 58:1629\u20131636","DOI":"10.1136\/gut.2009.182170"},{"key":"599_CR18","first-page":"228","volume":"6","author":"F Rieder","year":"2009","unstructured":"Rieder F, Fiocchi C (2009) Intestinal fibrosis in IBD\u2014a dynamic, multifactorial process. Nat Rev 6:228\u2013235","journal-title":"Nat Rev"},{"key":"599_CR19","doi-asserted-by":"crossref","unstructured":"Di Sabatino A, Jackson CL, Pickard KM et al (2009) Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease structures. Gut 58:777\u2013789","DOI":"10.1136\/gut.2008.149096"},{"key":"599_CR20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/ibd.20884","volume":"15","author":"F Heide van der","year":"2009","unstructured":"van der Heide F, Dijkstra A, Weersma RK et al (2009) Effects of active and passive smoking on disease course of Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis 15:1199\u20131207","journal-title":"Inflamm Bowel Dis"},{"key":"599_CR21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1473-3099(07)70211-6","volume":"7","author":"M Feller","year":"2007","unstructured":"Feller M, Huwiler K, Stephan R et al (2007) Mycobacterium avium subspecies paratuberculosis and Crohn\u2019s disease: a systematic review and meta-analysis. Lancet Infect Dis 7:607\u2013613","journal-title":"Lancet Infect Dis"},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","volume":"132","author":"W Selby","year":"2007","unstructured":"Selby W, Pavli P, Crotty B et al (2007) Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn\u2019s disease. Gastroenterology 132:2313\u20132319","journal-title":"Gastroenterology"},{"key":"599_CR23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2009.15","volume":"104","author":"S Singh","year":"2009","unstructured":"Singh S, Graff LA, Bernstein CN (2009) Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 104:1298\u20131313","journal-title":"Am J Gastroenterol"},{"key":"599_CR24","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","volume":"103","author":"JA Cornish","year":"2008","unstructured":"Cornish JA, Tan E, Simillis C et al (2008) The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 103:2394\u20132400","journal-title":"Am J Gastroenterol"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1053\/j.gastro.2009.01.075","volume":"136","author":"SM Collins","year":"2009","unstructured":"Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136:2003\u20132014","journal-title":"Gastroenterology"},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000228553","volume":"27","author":"PL Lakatos","year":"2009","unstructured":"Lakatos PL (2009) Environmental factors affecting inflammatory bowel disease: have we made progress? Dig Dis 27:215\u2013225","journal-title":"Dig Dis"},{"key":"599_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","volume":"6","author":"C Gasche","year":"2000","unstructured":"Gasche C, Scholmerich J, Brynskov J et al (2000) A simple classification of Crohn\u2019s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8\u201315","journal-title":"Inflamm Bowel Dis"},{"key":"599_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A et al (2002) Long-term evolution of disease behaviour of Crohn\u2019s disease. Inflamm Bowel Dis 8:244\u2013250","journal-title":"Inflamm Bowel Dis"},{"key":"599_CR29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","volume":"23","author":"C Canavan","year":"2006","unstructured":"Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 23:1097\u20131104","journal-title":"Aliment Pharmacol Ther"},{"key":"599_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW et al (1976) Development of a Crohn\u2019s disease activity index National Cooperative Crohn\u2019s Disease Study. Gastroenterology 70:439\u2013444","journal-title":"Gastroenterology"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.dld.2008.04.006","volume":"40","author":"M Fraquelli","year":"2008","unstructured":"Fraquelli M, Sarno A, Girelli C et al (2008) Reproducibility of bowel ultrasonography in the evaluation of Crohn\u2019s disease. Dig Liver Dis 40:860\u2013866","journal-title":"Dig Liver Dis"},{"key":"599_CR32","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3748\/wjg.v13.i24.3279","volume":"13","author":"S Saibeni","year":"2007","unstructured":"Saibeni S, Rondonotti E, Iozzelli A et al (2007) Imaging of the small bowel in Crohn\u2019s disease: a review of old and new techniques. World J Gastroenterol 13:3279\u20133287","journal-title":"World J Gastroenterol"},{"key":"599_CR33","first-page":"1915","volume":"16","author":"NC Gourtsoyiannis","year":"2006","unstructured":"Gourtsoyiannis NC, Grammatikakis J, Papamastorakis G et al (2006) Imaging of small intestinal Crohn\u2019s disease: comparison between MR enteroclysis and conventional enteroclysis. EurRadiol 16:1915\u20131925","journal-title":"EurRadiol"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1196\/annals.1326.014","volume":"1072","author":"M L\u00f6ffler","year":"2006","unstructured":"L\u00f6ffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci USA 1072:379\u2013385","journal-title":"Ann N Y Acad Sci USA"},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2007.03455.x","volume":"26","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ, Feagan BG, Lichtenstein GR (2007) Medical management of mild to moderate Crohn\u2019s disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther 26:987\u20131003","journal-title":"Aliment Pharmacol Ther"},{"key":"599_CR36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2008.03.014","volume":"6","author":"L Peyrin-Biroulet","year":"2008","unstructured":"Peyrin-Biroulet L, Deltenre P, de Suray N et al (2008) Efficacy and safety of tumor necrosis factor antagonists in Crohn\u2019s disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 6:644\u2013653","journal-title":"Clin Gastroenterol Hepatol"},{"key":"599_CR37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","volume":"2","author":"SB Hanauer","year":"2004","unstructured":"Hanauer SB, Wagner CL, Bala M et al (2004) Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn\u2019s disease. Clin Gastroenterol Hepatol 2:542\u2013553","journal-title":"Clin Gastroenterol Hepatol"},{"key":"599_CR38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","volume":"56","author":"S Vermeire","year":"2007","unstructured":"Vermeire S, Noman M, Van Assche G et al (2007) Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn\u2019s disease. Gut 56:1226\u20131231","journal-title":"Gut"},{"key":"599_CR39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/gast.2003.50145","volume":"124","author":"RJ Farrell","year":"2003","unstructured":"Farrell RJ, Alsahli M, Jeen YT et al (2003) Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn\u2019s disease: a randomized controlled trial. Gastroenterology 124:917\u2013924","journal-title":"Gastroenterology"},{"key":"599_CR40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","volume":"130","author":"SB Hanauer","year":"2006","unstructured":"Hanauer SB, Sandborn WJ, Rutgeerts P et al (2006) Human anti-tumour necrosis factor monoclonal antibody (adalimumab) in Crohn\u2019s disease: the CLASSIC-I trial. Gastroenterology 130:323\u2013333","journal-title":"Gastroenterology"},{"key":"599_CR41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","volume":"357","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ, Feagan BG, Stoinov S et al (2007) Certolizumabpegol for the treatment of Crohn\u2019s disease. N Engl J Med 357:228\u2013238","journal-title":"N Engl J Med"},{"key":"599_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(08)60995-2","volume":"372","author":"L Peyrin-Biroulet","year":"2008","unstructured":"Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF (2008) Crohn\u2019s disease: beyond antagonists of tumour necrosis factor. Lancet 372:67\u201381","journal-title":"Lancet"},{"key":"599_CR43","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1110-1194","volume":"16","author":"TT MacDonald","year":"2010","unstructured":"MacDonald TT (2010) Inside the microbial and immune labyrinth. Nat Med 16:1194\u20131195","journal-title":"Nat Med"},{"key":"599_CR44","unstructured":"MacDonald JK, McDonald JW (2007) Natalizumab for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev(1):CD006097"},{"key":"599_CR45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","volume":"4","author":"A Dignass","year":"2010","unstructured":"Dignass A, van Assche G, Lindsay JO, European Crohn\u2019s, Colitis Organisation (ECCO) et al (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: current management. J Crohns Colitis 4:28\u201362","journal-title":"J Crohns Colitis"},{"key":"599_CR46","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ibd.20915","volume":"15","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto T, Umegae S, Matsumoto K (2009) Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn\u2019s disease: a prospective pilot study. Inflamm Bowel Dis 15:1460\u20131466","journal-title":"Inflamm Bowel Dis"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-011-0599-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0599-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T16:02:46Z","timestamp":1560182566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-011-0599-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s11739-011-0599-2","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,8]]}}}